Matthew Rossiter

Partner

Fenwick & West

Office Phone:

(415) 875-2300

Direct Phone:

(415) 875-2372


  Pro - Try 1 Week Free
 

    and access,

  •     80K PE/M&A Contacts
  •     +
  •     4.6K PE Firms
  •     3.6K M&A Advisors
  •     198K Transactions
  •     202K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities

Bio

Matthew Rossiter represents fast-growing innovative businesses, ranging from entrepreneurs with a vision to established later-stage companies. With all his clients, large or small, he seeks to provide practical, creative and thoughtful advice to help them navigate legal challenges and pivotal transactions and achieve their business objectives. Matt is passionate about working with companies that are developing technological, scientific and business innovations that will transform industries and improve lives. He is a dedicated, responsive counselor and advocate for his clients, and seeks to be a long-term partner in the growth and success of his clients’ businesses. Matt has experience advising clients on a broad range of corporate and intellectual property matters. He assists early stage companies with establishing a solid legal foundation for future success, including selecting and implementing appropriate corporate structure, equity compensation and intellectual property protection arrangements. He also acts as outside general counsel to clients of all stages, helping them to proactively manage the legal aspects of their businesses, and to structure, negotiate and close business transactions quickly and effectively. Matt’s transactional experience includes seed and venture capital financings, strategic collaborations and joint ventures, debt financings, corporate reorganizations, mergers and acquisitions, and initial public offerings. He also advises executive management and boards of directors on legal and securities law compliance matters and corporate governance. Matt’s clients include leading public and private life sciences and technology companies, as well as many prominent venture capital firms. His life sciences experience spans a broad range of biopharmaceutical technologies and indications, as well as genomic and medical device technologies. Matt also has extensive experience with digital health and technology-enabled healthcare businesses. In the technology sector, Matt’s experience includes enterprise software, virtual currencies, autonomous vehicles and other industrial technologies.

Education